Comparison of Neoral and Sandimmun cyclosporines for de novo lung transplantation in cystic fibrosis patients

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1510-1511

  Mikhail, G ^a,b   Eadon, H ^a   Leaver, N ^a   Khaghani, A ^a   Yacoub, M ^a   Banner, N ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; OKT 3; THYMOCYTE ANTIBODY;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CYSTIC FIBROSIS; DRUG FORMULATION; DRUG SOLUBILITY; DRUG UPTAKE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MICROEMULSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE;

ADMINISTRATION, ORAL; ADULT; CYCLOSPORINE; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; RESPIRATORY INSUFFICIENCY;

EID: 0031832698     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00337-6     Document Type: Conference Paper

References (3)

1. Tsang VT, Johnston A, Heritier F, et al: Eur J Clin Pharmacol 46:261, 1994
2. Mikhail G, Eadon H, Leaver N, et al: Transplant Proc 26:2985, 1994
3. Mikhail G, Eadon H, Lever N, et al: Transplant Proc 29:599, 1997